Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion

Cancer

Volumn 107, Issue 8, 2006, Pages 1859-1865

  Benlloch, Susana ^a   Galbis Caravajal, Jose Marcelo ^a   Martín, Concepcion ^a   Sanchez Paya, Jose ^a   Rodríguez Paniagua, Jose Manuel ^a   Romero, Santiago ^a   Mafe, Juan Jose ^a   Massutí, Bartomeu ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Carcinoma; Diagnosis; DNA methylation; Pleural fluid; Polymerase chain reaction; Tumor marker

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P16INK4A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOMA; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DNA METHYLATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; THORACOCENTESIS;

ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 33750073529     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22190     Document Type: Article

References (30)

1. Ang P, Tan EH, Leong SS, et al. Primary intrathoracic malignant effusions: a descriptive study. Chest. 2001;120:50-54.
2. Light RW. Malignant pleural effusions. In: Light RW, editor. Pleural Diseases. 3rd ed. Baltimore: Williams & Williams; 1995:94-116.
3. Miedouge M, Rouzaud P, Salama G, et al. Evaluation of seven tumors markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer. 1999;81:1059-1065.
4. Demmy TL, Nwogu CH. Malignant pleural and pericardical effusions. In: Selke F, Swanson S, Del Nido PJ, editors. Sabiston & Spencer's Surgery of the Chest. 7th ed. Philadelphia: 2005:450.
5. Jones PA. DNA methylation errors and cancer. Cancer Res. 1996;56:2463-2467.
6. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16:168-174.
7. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-196.
8. Jones PA. The DNA methylation paradox. Trends Genet. 1999;15:34-37.
9. Soria JC, Rodriguez M, Liu D, Lee J, Hong KM, Mao L. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 2002;62:351-355.
10. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002;62:2370-2377.
11. Lu XP, Fanjul A, Picard N, et al. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat Med. 1997;3:686-690.
12. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000;25:315-319.
13. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
14. Kissil JL, Feinstein E, Cohen O, et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumour suppressor gene. Oncogene. 1997;15:403-407.
15. Tsou JA, Hagen JA, Carpenter CL, Laird-Offiga IA. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene. 2002;21:5450-5461.
16. Baylin SB, Belinsky SA, Herman JG. Aberrant methylation of gene promoters in cancer-concepts, misconcepts, and promise. J Natl Cancer Inst. 2000;92:1460-1461.
17. Ramirez J, Sarries C, de Castro P et al. Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Lett. 2003;193:207-216.
18. Ramirez J, Rosell R, Taron M, et al. 14-3-3Sigma methylation in pretreatment serum circulating DNA of cisplatinum-plus-gemcitabine-treated advanced non-small-cell-lung cancer patients predicts survival: The Spanish Lung Cancer Group. J Clin Oncol. 2005;23:9105-9112.
19. Topaloglu O, Hoque MO, Tokumaru CY, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res. 2004;10:2284-2288.
20. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:5954-5958.
21. Brock MV, Hooker CM, Yung R, et al. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg. 2005;80:1241-1247.
22. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821-9826.
23. Wingo PA, Ries LA, Giovino GA, et al. Annual report to the nation on the status of cancer 1973-1996. J Natl Cancer Inst. 1999;91:675-690.
24. Kim H, Know YM, Kim JS, et al. Tumor specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol. 2004;22:2363-2370.
25. Wong TS, Kwong DL, Sham JS, Wei WI, Kwong Y-L, Yuen A. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res. 2004;10:2401-2406,
26. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci. 2003;94:589-592.
27. Takahashi T, Shivapurkar N, Riquelme E, et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res. 2004; 10:6126-6133.
28. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59:67-70.
29. Romero S, Fernandez C, Arriero JM, et al. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J. 1996;9:17-23.
30. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000;28:e32.